Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-29 4:05 pm Purchase | 2024-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,435,000 9.200% | 305,000 (+26.99%) | Filing History |
| 2024-08-12 08:27 am Purchase | 2024-07-15 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 3,257,891 20.940% | 420,000 (+14.80%) | Filing History |
| 2024-07-25 8:48 pm Purchase | 2024-07-15 | 13G | CASI Pharmaceuticals, Inc. CASI | Venrock Healthcare Capital Partners III L.P. | 1,507,040 9.990% | 1,507,040 (New Position) | Filing History |
| 2024-06-20 9:00 pm Purchase | 2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI | Foresite Capital Fund VI, L.P. | 1,309,383 9.800% | 1,309,383 (New Position) | Filing History |
| 2024-06-11 4:10 pm Sale | 2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,130,000 8.400% | -1,565,000 (-58.07%) | Filing History |
| 2024-01-26 08:31 am Purchase | 2024-01-25 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 2,695,000 19.990% | 268,000 (+11.04%) | Filing History |
| 2023-11-09 4:13 pm Purchase | 2023-11-09 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 2,427,000 18.000% | 677,000 (+38.69%) | Filing History |
| 2023-06-22 9:15 pm Purchase | 2023-06-16 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,750,000 13.000% | 520,000 (+42.28%) | Filing History |
| 2023-04-18 4:00 pm Purchase | 2023-04-14 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,837,891 19.750% | 2,837,891 (New Position) | Filing History |
| 2023-04-10 11:22 am Purchase | 2023-03-29 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,230,000 9.200% | 1,230,000 (New Position) | Filing History |